Read Full Report
Date: Feb. 4, 2009
Contacts: Christine Stencel, Media Relations Officer
Luwam Yeibio, Media Relations Assistant
Office of News and Public Information
202-334-2138; e-mail <email@example.com>
for immediate release
HIPAA Privacy Rule Fails to Adequately Protect Patient Privacy and Hampers
Health Research; A New Approach to Privacy Protection Is Needed in Research
WASHINGTON -- The Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule does not adequately protect the privacy of people's personal health information and hinders important health research discoveries, concludes a new report from the Institute of Medicine.
Congress should authorize the development of an entirely new approach to protecting personal health information in research, separate from the HIPAA Privacy Rule, said the committee that wrote the report. This new approach should apply privacy, data security, and accountability standards uniformly to information used in all health-related research regardless of who funds or conducts the research.
If policymakers decide to continue relying on the current rule to protect privacy in health research, the committee recommends a series of changes to improve the rule and the guidance that the U.S. Department of Health and Human Services (HHS) gives on how to comply with it.
In addition, the report urges all institutions conducting health research to strengthen their data protection. Security breaches are a growing problem for health information databases. Among the measures that should be taken, encryption should be required for all laptops, flash drives, and other portable media containing such data given the potential for these items to be lost or stolen.
The committee's recommendations recognize the valuable societal benefits that both ethically conducted health research and privacy protections provide. Without such research, society would lose the benefit of new therapies, improved diagnostics, and more effective ways to prevent illness and deliver care. Privacy helps protect individuals from harm, such as discrimination and identity theft, and permits research and public health activities to be carried out in ways that preserve their dignity.
"We believe there is synergy between the goals of safeguarding privacy and enhancing health research and that it is critically important to our nation's health to strengthen privacy protections and still facilitate research," said committee chair Lawrence O. Gostin, professor of law and director, O'Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, D.C. "Our recommendations aim to boost regulations and practices that effectively protect personally identifiable health information, while changing provisions of the HIPAA Privacy Rule or its interpretations that have proved to be ineffective."
The HIPAA Privacy Rule regulates what uses and disclosures of personally identifiable health information are permitted by health plans, health care providers, and other entities covered by the regulation. The goal is to ensure that individuals' health information is properly protected while allowing the flow of data needed to promote high-quality health care and health-related research.
However, the HIPAA Privacy Rule is difficult to reconcile with other federal regulations governing research involving people and their personally identifiable information. Moreover, organizations that collect and use health data vary greatly in how they interpret and follow the rule, and the rule does not apply uniformly to all health research. The committee's review of published reports, testimony from patient and privacy advocates and the health research community, and other sources of information led it to conclude that the way the rule is currently interpreted does not adequately protect privacy and impedes important health research.
HHS and other federal agencies should develop a new approach to regulation that focuses on best practices in privacy, security, and transparency, the report says. The new framework should facilitate use of health data in which personally identifiable information is removed and should provide legal sanctions against unauthorized re-identification of individuals. It should provide ethical oversight of research in which use of personally identifiable information without individual consent is necessary. This oversight could be accomplished by local ethical review boards that assess proposed projects on a case-by-case basis, or institutions could be certified at the federal level to carry out this kind of research, having proved they have policies and practices in place to protect data privacy and ensure security.
If the current HIPAA Privacy Rule continues to be the means for safeguarding privacy in health-related research, the committee recommended several ways to revise the rule and its guidance on compliance. For example, HHS should make it clear that people can grant permission in advance that samples or data collected from them for one research project can be used in future research. And the agency should simplify and clarify the criteria for making decisions about waiving requirements to obtain permission from every patient whose personal health information will be used in study.
The study was sponsored by the U.S. Department of Health and Human Services, Robert Wood Johnson Foundation, American Cancer Society, American Heart Association/American Stroke Association, American Society for Clinical Oncology, Burroughs Wellcome Fund, and C-Change. Established in 1970 under the charter of the National Academy of Sciences, the Institute of Medicine provides independent, objective, evidence-based advice to policymakers, health professionals, the private sector, and the public. The National Academy of Sciences, National Academy of Engineering, Institute of Medicine, and National Research Council make up the National Academies. A committee roster follows.
Pre-publication copies of Beyond the HIPAA Privacy Rule: Enhancing Privacy, Improving Health Through Research are available from the National Academies Press; tel. 202-334-3313 or 1-800-624-6242 or on the Internet at http://www.nap.edu. Additional information on the report can be found at http://www.iom.edu/hipaa. Reporters may obtain a copy from the Office of News and Public Information (contacts listed above).
# # #
[ This news release and report are available at http://national-academies.org ]
INSTITUTE OF MEDICINE
Board on Health Sciences Policy
Committee on Health Research and the Privacy of Health Information: The HIPAA Privacy Rule
Lawrence O. Gostin, J.D. (chair)
Professor of Law
Georgetown University Law Center
Paul Appelbaum, M.D.
Professor of Psychiatry, Medicine, and
Division of Psychiatry, Law, and Ethics
Columbia University Psychiatric Institute
New York City
Elizabeth Beattie, Ph.D.
School of Nursing
Faculty of Health Sciences
The Queensland University of Technology
Marc Boutin, J.D.
Policy, Development, and Advocacy
National Health Council
Thomas W. Croghan, M.D.
Mathematica Policy Research Inc.
Stanley W. Crosley
Chief Privacy Officer
Eli Lilly and Co.
Sandra J. Horning, M.D.
Professor of Medicine and Oncology
Stanford School of Medicine
Palo Alto, Calif.
James S. Jackson, Ph.D.
Institute for Social Research
University of Michigan
Mary Beth Joublanc, J.D.
Chief Privacy Officer
State of Arizona
Arizone Government Technology Agency
Bernard Lo, M.D.
Professor of Medicine and
Program in Medical Ethics
University of California
Andrew F. Nelson, M.P.H.
HealthPartners Research Foundation
Marc Rotenberg, J.D.
Electronic Privacy Information Center
Wendy Visscher, Ph.D.
Office of Research Protection
Research Triangle Park, N.C.
Fred Wright, M.D.
Associate Chief of Staff for Research
VA Connecticut Healthcare System
Clyde W. Yancy, M.D.
Baylor Heart and Vascular Institute
Baylor University Medical Center
INSTITUTE OF MEDICINE STAFF
Sharyl Nass, Ph.D.